FDA clocks record number of recalls

Share this article:

The FDA is setting a record. Regulatory Focus reports that the regulator has issued more recalls since the beginning of 2013 than it did over the previous nine years. RF says the record-breaking streak is punctuated by a spike in Class-II recalls, which means drugmakers pulled items which may cause “temporary or medically reversible adverse events.”

RF says Class-II recalls have become a mainstay of total recall numbers for a while, and that the uptick is linked to compounding pharmacies which have undergone increased scrutiny since the 2012 fungal meningitis outbreak that killed more than 60 patients.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.